Implementing EEG & Digital Biomarkers for Neuropsychiatric Indications – Navigating Pharmacology Confirmation, At-Home Monitoring & Technology Selection
1:30 pm - Tuesday 1st December 2026
- Discover how EEG biomarkers confirm GABAergic pharmacology translationally from rodents to healthy volunteers, providing dose navigation and PK-PD relationships in Phase 1 studies, while understanding the critical limitation of clinical translation
- Explore emerging at-home EEG technologies that enable remote data acquisition in psychiatric patient populations, addressing the operational challenges of implementing EEG in large Phase 2
- Comparing vendor selection criteria when evaluating digital biomarker technologies for neuropsychiatric trials and balancing selecting technologies that deliver reproducible, interpretable results that satisfy both scientific rigor and operational feasibility
